Literature DB >> 19342877

A highly efficient system to produce infectious human papillomavirus: Elucidation of natural virus-host interactions.

Louise T Chow1, Aaron A Duffy, Hsu-Kun Wang, Thomas R Broker.   

Abstract

A simple, efficient system has been developed to produce high titers of infectious human papillomavirus type 18 (HPV-18) in organotypic raft cultures of primary human keratinocytes (PHKs). Molecular characterization elucidated key early and late events in the reproductive program. The system obviates the need for immortalized cells and allows the analyses of mutant HPV genomes not previously possible. An E6 deletion mutant incapable of causing p53 degradation is defective in viral DNA amplification and capsid protein production. The high levels of p53 protein which accumulated in numerous cells did not lead to apoptosis over a prolonged duration. Time course and metabolic labeling experiments revealed novel interactions with the host. Notably, post-mitotic, differentiated cells are induced by HPV E7 expression to reenter S phase, whereupon host chromosomes replicate, but HPV DNA does not amplify until the cells have progressed to and are arrested in G(2) phase. Here, we present data that strongly suggest that the abundant cytoplasmic viral E1;E4 protein is not responsible for this G(2) arrest, as described in the literature upon ectopic expression in cell lines. We provide additional insights into the viral life cycle and contrast them to conclusions derived from experiments in cell lines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342877     DOI: 10.4161/cc.8.9.8242

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  17 in total

1.  A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1^E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression.

Authors:  Gillian L Knight; Alice G Pugh; Emma Yates; Ian Bell; Regina Wilson; Cary A Moody; Laimonis A Laimins; Sally Roberts
Journal:  Virology       Date:  2011-01-31       Impact factor: 3.616

2.  The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci.

Authors:  Nozomi Sakakibara; Ruchira Mitra; Alison A McBride
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

Review 3.  Modulation of the DNA damage response during the life cycle of human papillomaviruses.

Authors:  Daniel C Anacker; Cary A Moody
Journal:  Virus Res       Date:  2016-11-09       Impact factor: 3.303

4.  Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes.

Authors:  N Sanjib Banerjee; Hsu-Kun Wang; Thomas R Broker; Louise T Chow
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

5.  Development of a cellular assay system to study the genome replication of high- and low-risk mucosal and cutaneous human papillomaviruses.

Authors:  Jelizaveta Geimanen; Helen Isok-Paas; Regina Pipitch; Kristiina Salk; Triin Laos; Marit Orav; Tormi Reinson; Mart Ustav; Mart Ustav; Ene Ustav
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

6.  HPV Type 16 Infection Switches Keratinocytes from Apoptotic to Proliferative Fate under TWEAK/Fn14 Interaction.

Authors:  Hong Cheng; Na Zhan; Dong Ding; Xiaoming Liu; Xiaoyan Zou; Ke Li; Yumin Xia
Journal:  J Invest Dermatol       Date:  2015-05-27       Impact factor: 8.551

7.  Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.

Authors:  Carolina Scagnolari; Fabiana Cannella; Alessandra Pierangeli; Rebecca Mellinger Pilgrim; Guido Antonelli; Dayana Rowley; Margaret Wong; Simon Best; Deyin Xing; Richard B S Roden; Raphael Viscidi
Journal:  J Virol       Date:  2020-06-01       Impact factor: 5.103

Review 8.  Human papillomavirus infections: warts or cancer?

Authors:  Louise T Chow; Thomas R Broker
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

Review 9.  Human papilloma virions in the laboratory.

Authors:  Eileen F Dunne; Lauri E Markowitz; La'shan D Taylor; Elizabeth R Unger; Cosette M Wheeler
Journal:  J Clin Virol       Date:  2014-06-23       Impact factor: 3.168

Review 10.  Cellular receptor binding and entry of human papillomavirus.

Authors:  Tan Letian; Zhang Tianyu
Journal:  Virol J       Date:  2010-01-06       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.